Ainnova Tech is a verified healthtech startup with significant B2B traction, including strategic partnerships with Apollo Hospitals, Avant Technologies, and Roche/Salud 360 for its 'VisionAi' retinal screening platform. While the user submission contained lazy and inaccurate text (claiming 'most people' have used it and audience is 'everyone'), independent verification confirms the company's legitimacy, global awards, and active commercial agreements in the US and Latin America. The project has high real-world utility in preventing blindness and detecting diabetes early, scoring well on innovation and market timing. The final score is heavily penalized by the low quality of the submission but buoyed by strong external evidence of utility and traction.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline